| Antimicrobial Agent | Susceptibility Profile | Clinical Interpretation |
|---|---|---|
| Amikacin | Sensitive | 4 |
| Amoxicillin/Clavulanic acid | Resistant | >=32 |
| Cefepime | Sensitive | 2 |
| Ceftriaxone | Sensitive | 1 |
| Cefuroxime | Resistant | >=64 |
| Ciprofloxacin | Resistant | >=4 |
| Colistin | Intermediate | <=0.5 |
| Ertapenem | Sensitive | 0.25 |
| Gentamicin | Sensitive | <=1 |
| Imipenem | Sensitive | <=0.25 |
| Meropenem | Sensitive | <=0.25 |
| Piperacillin/Tazobactam | Resistant | >=128 |
| Trimethoprim/Sulfamethoxazole | Sensitive | 40 |
| Resistant Gene Track | Detection Methodology | NCBI Genome Accession |
|---|---|---|
| oqxA | PCR | |
| oqxB | PCR |